Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

4.99USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,149
52-wk High
$9.49
52-wk Low
$1.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.074
Jun '18 0.00 -0.107
Mar '18 0.00 -0.122
FY 2017 Dec '17 0.00 -0.073
Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 2.85 0.66 0.95
Price to Sales (TTM) -- 242.95 21.76
Price to Book (MRQ) 10,467.01 18.87 4.53
Price to Tangible Book (MRQ) 21.00 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.85 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 32.17 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 6.40 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -- -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -- -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -- -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -- -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 28,103,806 878,349,382
Net Income/Employee (TTM) -1,890,286 -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.00 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -150.13 0.35 11.06
Return on Assets - 5 Yr. Avg. -95.66 2.90 11.85
Return on Investment (TTM) -227.35 0.60 13.80
Return on Investment - 5 Yr. Avg. -109.96 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -259.75 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 16.24 16.26 88 99
13 Week 0.22 8.27 79 94
26 Week 2.46 2.75 76 96
52 Week 68.38 63.31 88 98
YTD 37.13 36.69 84 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.53%
# of Holders: 67
Total Shares Held: 5,979,018
3 Mo. Net Change: 398,614
# New Positions: 13
# Closed Positions: 21
# Increased Positions: 35
# Reduced Positions: 37
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.